title: Successful treatment of low dose cytosine arabinoside for acute myelofibrosis with immature myeloblast (AML-MO)
authors.forename: H
authors.initials: H
authors.lastname: Kanamori
authors.forename: J
authors.initials: J
authors.lastname: Tanabe
authors.forename: T
authors.initials: T
authors.lastname: Koike
authors.forename: Y
authors.initials: Y
authors.lastname: Hashimoto
authors.forename: M
authors.initials: M
authors.lastname: Matsuzaki
authors.forename: H
authors.initials: H
authors.lastname: Kitamura
authors.forename: S
authors.initials: S
authors.lastname: Motomura
authors.forename: H
authors.initials: H
authors.lastname: Mohri
authors.forename: T
authors.initials: T
authors.lastname: Ohkubo
mesh_terms: D000208:Acute Disease; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000188:drug therapy*
chemical_list: D003561:Cytarabine